1. Home
  2. JTAI vs SPRC Comparison

JTAI vs SPRC Comparison

Compare JTAI & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jet.AI Inc.

JTAI

Jet.AI Inc.

HOLD

Current Price

$0.10

Market Cap

4.6M

Sector

Finance

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$4.60

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JTAI
SPRC
Founded
2018
2004
Country
United States
Israel
Employees
8
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
4.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
JTAI
SPRC
Price
$0.10
$4.60
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$0.40
N/A
AVG Volume (30 Days)
16.9M
105.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$0.23
52 Week High
$6.35
$8.90

Technical Indicators

Market Signals
Indicator
JTAI
SPRC
Relative Strength Index (RSI) 29.41 68.54
Support Level $0.09 $3.62
Resistance Level $0.13 $4.85
Average True Range (ATR) 0.01 0.51
MACD 0.02 0.29
Stochastic Oscillator 36.57 69.93

Price Performance

Historical Comparison
JTAI
SPRC

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: